TG Therapeutics Inc. monthly returns
TG Therapeutics Inc. has averaged 4.19% per month, positive in 50% of months. Month-by-month returns for TG Therapeutics Inc. (TGTX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
TG Therapeutics Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -3.2% | |
| Sep 2026 | +2.7% | |
| Aug 2026 | +4.4% | |
| Jul 2026 | -5.3% | |
| Jun 2026 | +44.8% | |
| May 2026 | +12.3% | |
| Apr 2026 | +1.7% | |
| Mar 2026 | +10.4% | |
| Feb 2026 | +2.2% | |
| Jan 2026 | -1.3% | |
| Dec 2025 | -10.4% | |
| Nov 2025 | -4.4% | |
| Oct 2025 | -3.7% | |
| Sep 2025 | +23.2% | |
| Aug 2025 | -17.4% | |
| Jul 2025 | -1.4% | |
| Jun 2025 | +2.5% | |
| May 2025 | -22.9% | |
| Apr 2025 | +15.4% | |
| Mar 2025 | +31.0% | |
| Feb 2025 | -5.1% | |
| Jan 2025 | +5.3% | |
| Dec 2024 | -13.5% | |
| Nov 2024 | +38.9% | |
| Oct 2024 | +7.1% | |
| Sep 2024 | -0.4% | |
| Aug 2024 | +18.9% | |
| Jul 2024 | +11.1% | |
| Jun 2024 | +9.1% | |
| May 2024 | +19.3% | |
| Apr 2024 | -10.2% | |
| Mar 2024 | -11.7% | |
| Feb 2024 | +6.0% | |
| Jan 2024 | -4.9% | |
| Dec 2023 | +33.3% | |
| Nov 2023 | +65.7% | |
| Oct 2023 | -7.5% | |
| Sep 2023 | -20.2% | |
| Aug 2023 | -49.4% | |
| Jul 2023 | -16.7% | |
| Jun 2023 | -6.7% | |
| May 2023 | +7.2% | |
| Apr 2023 | +65.1% | |
| Mar 2023 | -6.1% | |
| Feb 2023 | +5.2% | |
| Jan 2023 | +28.7% | |
| Dec 2022 | +34.1% | |
| Nov 2022 | +51.5% | |
| Oct 2022 | -1.7% | |
| Sep 2022 | -17.0% | |
| Aug 2022 | +19.0% | |
| Jul 2022 | +40.9% | |
| Jun 2022 | -3.8% | |
| May 2022 | -36.3% | |
| Apr 2022 | -27.0% | |
| Mar 2022 | -3.6% | |
| Feb 2022 | -14.7% | |
| Jan 2022 | -39.1% | |
| Dec 2021 | +25.0% | |
| Nov 2021 | -51.3% | |
| Oct 2021 | -6.2% | |
| Sep 2021 | +22.9% | |
| Aug 2021 | -22.6% | |
| Jul 2021 | -9.8% | |
| Jun 2021 | +11.2% | |
| May 2021 | -22.0% | |
| Apr 2021 | -7.2% | |
| Mar 2021 | +10.1% | |
| Feb 2021 | -9.3% | |
| Jan 2021 | -7.2% | |
| Dec 2020 | +77.3% | |
| Nov 2020 | +16.1% | |
| Oct 2020 | -5.6% | |
| Sep 2020 | +7.9% | |
| Aug 2020 | +26.7% | |
| Jul 2020 | +0.5% | |
| Jun 2020 | +4.5% | |
| May 2020 | +58.6% | |
| Apr 2020 | +19.5% | |
| Mar 2020 | -21.6% | |
| Feb 2020 | -11.7% | |
| Jan 2020 | +28.0% | |
| Dec 2019 | +35.5% | |
| Nov 2019 | +19.9% | |
| Oct 2019 | +21.6% | |
| Sep 2019 | -9.6% | |
| Aug 2019 | -17.1% | |
| Jul 2019 | -13.4% | |
| Jun 2019 | +38.0% | |
| May 2019 | -21.1% | |
| Apr 2019 | -1.1% | |
| Mar 2019 | +18.2% | |
| Feb 2019 | +65.9% | |
| Jan 2019 | +0.0% | |
| Dec 2018 | -18.7% | |
| Nov 2018 | +10.8% | |
| Oct 2018 | -18.8% | |
| Sep 2018 | -55.9% | |
| Aug 2018 | +8.1% | |
| Jul 2018 | -10.6% | |
| Jun 2018 | -1.9% | |
| May 2018 | -6.6% | |
| Apr 2018 | +1.1% | |
| Mar 2018 | +1.4% | |
| Feb 2018 | +21.7% | |
| Jan 2018 | +40.2% | |
| Dec 2017 | -4.7% | |
| Nov 2017 | +5.5% | |
| Oct 2017 | -31.2% | |
| Sep 2017 | -6.7% | |
| Aug 2017 | +10.4% | |
| Jul 2017 | +14.4% | |
| Jun 2017 | -10.7% | |
| May 2017 | +1.8% | |
| Apr 2017 | -5.2% | |
| Mar 2017 | +104.4% | |
| Feb 2017 | +18.8% | |
| Jan 2017 | +3.2% | |
| Dec 2016 | -19.1% | |
| Nov 2016 | +7.5% |
Monthly total return (since Nov 2021)#
TG Therapeutics Inc. returns by calendar month#
Every month of every year since 2011, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -3.24% — 6th of 16 Octobers since 2011 at the last close; the average October returned -8.7%.
| Month | −200%0+200% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +20.9% | +2.6% | 56% | +200.0% 2012 | -39.1% 2022 | |
| Feb | +15.2% | +2.9% | 69% | +183.3% 2012 | -36.7% 2011 | |
| Mar | +8.2% | +3.4% | 63% | +104.4% 2017 | -29.4% 2012 | |
| Apr | +1.6% | -0.6% | 44% | +65.1% 2023 | -27.0% 2022 | |
| May | +1.1% | +3.3% | 56% | +58.6% 2020 | -36.3% 2022 | |
| Jun | +3.7% | +1.2% | 50% | +44.8% 2026 | -53.8% 2011 | |
| Jul | -1.3% | -3.4% | 31% | +40.9% 2022 | -16.7% 2023 | |
| Aug | -8.1% | +1.4% | 50% | +26.7% 2020 | -60.0% 2012 | |
| Sep | -5.3% | -8.1% | 38% | +25.8% 2014 | -55.9% 2018 | |
| Oct | -8.7% | -6.2% | 27% | +22.7% 2015 | -45.5% 2011 | |
| Nov | +14.9% | +10.8% | 73% | +65.7% 2023 | -51.3% 2021 | |
| Dec | +8.7% | -4.7% | 47% | +77.3% 2020 | -66.7% 2011 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from TGTX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is TG Therapeutics Inc.'s average monthly return?
- TG Therapeutics Inc. (TGTX) has averaged about 4.19% per month, positive in roughly 50% of months. The best month was Jan 2012 (+200.0%) and the worst was Dec 2011 (-66.7%).
